Does adding REBOA to advanced life support improve outcomes in non-traumatic out-of-hospital cardiac arrest? This appraisal of REBOARREST examines the neutral trial results, delays to aortic occlusion and incomplete delivery of the intervention, and asks what remains uncertain.
Does prehospital whole blood improve outcomes compared with blood components in traumatic haemorrhage? We critically appraise the SWiFT randomised trial, including its findings on death or massive transfusion within 24 hours and the limits of testing a prehospital-only intervention.
A review of the 2026 AHA/ACC multi-society guideline on acute pulmonary embolism, covering its A–E clinical categories, diagnostic approach, treatment and follow-up. The article considers the changes alongside UK practice and explains where the author sees their greatest relevance.
Emergency medicine research rarely provides certainty, but it can guide decisions. At The Big Sick (TBS) conference 2026, we presented papers challenging assumptions around trauma, airway management, resuscitation systems and rare high-stakes decisions. This post reviews the best emergency medicine papers from 2025–2026, focusing on what they mean for clinicians working at the front door.
A retrospective review of 600 patients treated for suspected sepsis in US emergency departments raises questions about antibiotic overtreatment. We examine the study’s use of hindsight, possible treatment-related harms and how its findings translate to UK practice.
Conference ReportsEvidence-Based Medicine
Iain and Simon review the February 2025 posts, from maintaining rarely used procedural skills to diastolic pressure during resuscitation. They also discuss resuscitative hysterotomy and the updated guidance on diagnosing death.
Practical perspectives on trauma care and team leadership.
Explore the series →